bioRxiv 25 nov. 2025 Targeting Metabolic Vulnerabilities: Valinomycin Augments the Potency of Bioenergetic Inhibitors in Combatting Drug-Resistant and Dormant Mycobacterium tuberculosis #Metabolic Vulnerabilities #Dormant Mycobacterium
FierceBiotech 25 nov. 2025 <a href="https://www.fiercebiotech.com/biotech/contineums-jj-partnered-ms-drug-fails-improve-vision-phase-2" hreflang="en">Contineum's J&J-partnered MS drug fails to improve vision in phase 2</a> #Contineum Therapeutics’ #receptor antagonist
FierceBiotech 25 nov. 2025 <a href="https://www.fiercebiotech.com/biotech/jjs-5b-alzheimers-hope-fades-anti-tau-antibody-posdinemab-flops-phase-2" hreflang="en">J&J's $5B Alzheimer's hope fades as anti-tau antibody posdinemab flops in phase 2</a> #Alzheimer hope #anti-tau antibody
Endpoints News 24 nov. 2025 UK-US drug pricing deal could come as early as this week, sources say #told Endpoints #UK-US drug
BioWorld 24 nov. 2025 Bayer’s asundexian hits phase III stroke goal in win for FXIa drugs #phase III #drugs Detailed
PharmaVoice 24 nov. 2025 Eli Lilly becomes first drugmaker to hit $1 trillion in market value #Eli Lilly #drugmaking peers
Endpoints News 21 nov. 2025 Teva loses IRA drug pricing challenge in DC federal court #federal court #loses IRA
Endpoints News 21 nov. 2025 Contineum's J&J-partnered drug fails Phase 2 multiple sclerosis trial #Thursday afternoon #fails Phase
Endpoints News 21 nov. 2025 GSK, AnaptysBio enter legal battle over decade-old Jemperli licensing deal #decade-old Jemperli #drug Jemperli
BioPharma Dive 21 nov. 2025 Eli Lilly becomes first drugmaker to hit $1 trillion in market value #Eli Lilly #drugmaking peers
BioPharma Dive 21 nov. 2025 FDA tests new program to speed drugmaker talks; Bezos-linked AI startup raises $106M #quick clarifications #FDA tests
Roche Media 19 nov. 2025 Roche: Data for Breast Cancer Drug Candidate Giredestrant Support Potential Differentiated Status - Morningstar Canada #Breast Cancer #Cancer Drug
PharmaVoice 19 nov. 2025 As Madrigal faces MASH rivals, keeping patients is as critical as finding new ones #MASH rivals #faces MASH
Roche Media 18 nov. 2025 OLMA Stock Doubles After Roche Cancer Drug Trial Yields Positive Results - Stocktwits #Stock Doubles #Roche Cancer
Roche Media 18 nov. 2025 New experimental drug could transform care for cancer patients - The Independent #experimental drug #transform care
Roche Media 18 nov. 2025 Is Now the Moment to Reassess Roche After Its Drug Pipeline Developments and 17% Stock Jump? - simplywall.st #Stock Jump #Reassess Roche